Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles
about
The l2 minor capsid protein of human papillomavirus type 16 interacts with a network of nuclear import receptorsRole of rubella virus glycoprotein domains in assembly of virus-like particles.Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection.Prophylactic human papillomavirus vaccinesIdentification of human papillomavirus type 16 L1 surface loops required for neutralization by human seraAssociation of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinomaTissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virionsThe l2 minor capsid protein of low-risk human papillomavirus type 11 interacts with host nuclear import receptors and viral DNAPapillomavirus Infectious Pathways: A Comparison of SystemsConcepts of papillomavirus entry into host cellsImmunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.Structural Basis of Oligosaccharide Receptor Recognition by Human PapillomavirusDifferentiation-dependent interpentameric disulfide bond stabilizes native human papillomavirus type 16Papillomavirus prophylactic vaccines: established successes, new approaches.Efficient Production of Papillomavirus Gene Delivery Vectors in Defined In Vitro Reactions.The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.The role of furin in papillomavirus infection.Use of the normalized absorbance ratio as an internal standardization approach to minimize measurement error in enzyme-linked immunosorbent assays for diagnosis of human papillomavirus infectionSystemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model.Roles for human papillomavirus type 16 l1 cysteine residues 161, 229, and 379 in genome encapsidation and capsid stabilityThe papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domainsNasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretionsIn vitro construction of pseudovirions of human papillomavirus type 16: incorporation of plasmid DNA into reassembled L1/L2 capsids.Gene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16.Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunityCharacterization of a major neutralizing epitope on human papillomavirus type 16 L1Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of miceGeneration of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies.Roles of disulfide linkage and calcium ion-mediated interactions in assembly and disassembly of virus-like particles composed of simian virus 40 VP1 capsid protein.L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidationPositively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection.Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice.Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 l1 capsomers.Time course of humoral and cell-mediated immune responses to human papillomavirus type 16 in infected women.Detection of neutralizing antibodies against human papillomaviruses (HPV) by inhibition of gene transfer mediated by HPV pseudovirions.Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccineImmunotherapy for cervical cancer: Research status and clinical potential
P2860
Q24309388-2DB2BF41-5203-49F6-AAE3-419830B068CBQ24517120-E5313455-7AC2-40C7-A9BB-0C9FCBE99A5DQ24524176-85EFC3F8-F66B-4EDE-9662-86F7585BB3C5Q24545449-79E9105E-4CD0-417C-87B0-4E99802D867CQ24545868-B0D3A688-4A0E-4EA8-B026-14747315FDBCQ24644897-3B4D779B-437A-4C59-A12D-B60934B3F468Q24646183-A4CED37A-4830-4982-9448-7A422C446E4FQ24674159-0754EADD-E4E6-41E6-9836-0C4ED9B78829Q26801497-4D6CB454-FFAC-4217-A21C-541C6369E2DCQ27026900-F78FF4FA-C823-465A-BA12-69DBCCAD6B1FQ27307719-2696F387-CF88-41DD-803D-3FCD02DE0B7FQ27666101-EEF83607-09AB-4C4E-A628-E24C9CAB3CBAQ28479209-CCCFAE35-AA98-4213-81AA-7DE496278E54Q33614425-3B9BE4D6-1742-4C1C-AA9D-A6743984F0AFQ33652425-CA3BDE50-7B04-4A35-88FF-F138E36F31D2Q33673620-6B2EE8F3-5E4A-408D-8B66-9B42F8FE9116Q33693739-A2D062EE-0798-400A-BFB2-A588FDE03BAFQ33704870-6620BBDB-E526-430A-8389-6D712908CFA8Q33707499-AC9FA253-E74D-445B-97BD-376686F1EE2BQ33728320-91A608D4-ABD8-4368-910A-6A4308CA47A6Q33740579-74C4FDD1-A9DA-4500-9E42-A7A1D1951BB0Q33781905-2DE8E9B0-F450-484C-A561-3B2D3C0254B6Q33784891-777BEAF5-8E5A-415A-8E08-A9E87A354D0AQ33786402-DAD3B72B-9685-4E6B-9D81-E7FA25787E14Q33787204-A6E6F824-0BAE-4C42-97C5-DF473268C810Q33788885-48E5E0E3-CE03-488E-9FAB-A17093203D04Q33797578-CAAA9DA1-EB57-4016-A480-78D045481095Q33813986-BD0BFF06-5915-4E7C-8069-C41612F53905Q33823755-8DABFEBD-3DC1-4061-9B37-8EF04A3C58CDQ33827126-B8453799-E570-4766-BE61-BD364365DA66Q33834481-A15069C8-DE73-4516-9F74-633DED71CE63Q33839721-846AA85E-E51B-4650-B0EB-E378C5A4EB3AQ33848323-93611F69-53DF-4ECC-A54F-F46F6AD20E7EQ33850734-C5685179-0A45-46B5-89A9-CDDB3F95AC3AQ33877406-A415C64F-F79B-473C-AC00-2E4EBA3717F0Q33908917-A9719F35-9685-4E1E-A3C3-5646068B12A1Q33944133-014A11A2-2127-4CE9-8F6F-49F055BDFBDEQ33950282-E3B415B9-688A-4117-B4A2-DEAD5B514691Q34032367-545E7629-E9F6-45C3-8C6C-B8F82D72108CQ34033763-8540B7EC-9574-4896-B110-EB5455A232F0
P2860
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Efficient self-assembly of hum ...... 1-L2 into virus-like particles
@ast
Efficient self-assembly of hum ...... 1-L2 into virus-like particles
@en
type
label
Efficient self-assembly of hum ...... 1-L2 into virus-like particles
@ast
Efficient self-assembly of hum ...... 1-L2 into virus-like particles
@en
prefLabel
Efficient self-assembly of hum ...... 1-L2 into virus-like particles
@ast
Efficient self-assembly of hum ...... 1-L2 into virus-like particles
@en
P2093
P2860
P1433
P1476
Efficient self-assembly of hum ...... 1-L2 into virus-like particles
@en
P2093
H Greenstone
J T Schiller
L Gissmann
R Kirnbauer
P2860
P304
P407
P577
1993-12-01T00:00:00Z